INTERNATIONAL PATENT: FORTVITA BIOLOGICS INC., 福佑泰生物制药公司 FILES APPLICATION FOR "HETEROBICYCLIC COMPOUNDS USABLE AS GLP-1R AGONISTS"

GENEVA, Dec. 8 -- FORTVITA BIOLOGICS INC. (Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay RoadGrand Cayman KY1-1205), 福佑泰生物制药公司 (开曼群岛大开曼岛西湾路802号，扶桑花路，格兰德大厦，邮政信箱31119) filed a patent application (PCT/CN2025/098519) for "HETEROBICYCLIC COMPOUNDS USABLE AS GLP-1R AGONISTS" on May 30, 2025. With publication no. WO/2025/247390, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under ...